Tmunity IPO

Tmunity is a clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T-cell immunotherapy to patients with devastating diseases.

Register for Details

For more details on financing and valuation for Tmunity, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Tmunity Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
6/27/2022 Series C $129.44MM $XXX.XX $XXX.XX
10/31/2019 Series B $410.37MM $XXX.XX $XXX.XX
4/19/2018 Series A $309.54MM $XXX.XX $XXX.XX
1/12/2016 Series Seed $43.39MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Tmunity

Forge green plus iconForge green minus icon

What is Tmunity funding to date?

Tmunity has raised $292.52MM with the following series:
$43.39MM for Series Seed, $309.54MM for Series A, $410.37MM for Series B, $129.44MM for Series C, $43.39MM for Series Seed, $309.54MM for Series A, $410.37MM for Series B, $129.44MM for Series C.
Forge green plus iconForge green minus icon

When was Tmunity founded?

Tmunity was founded in 2015.